Novartis completes Alcon spin-off

Alcon is now trading as an independent company as its spin-off from Novartis has been completed, the companies announced.
Shares of Alcon, the world’s largest eye care device company, began trading today on the SIX Swiss Exchange and the New York Stock Exchange under the symbol ALC.
“For more than 70 years, Alcon has been dedicated to helping people see brilliantly and now, as an independent company, we are pursuing even more opportunities to further that mission,” David Endicott, Alcon CEO, said in a press release. “We are poised to (Read more...)

Full Story →